Factors that influence variation in clinical decision-making about thrombolysis in the treatment of acute ischaemic stroke: results of a discrete choice experiment
Background: Intravenous thrombolysis for patients with acute ischaemic stroke is underused (only 80% of eligible patients receive it) and there is variation in its use across the UK. Previously, variation might have been explained by structural differences; however, continuing variation may reflect...
Main Authors: | Richard G Thomson, Aoife De Brún, Darren Flynn, Laura Ternent, Christopher I Price, Helen Rodgers, Gary A Ford, Matthew Rudd, Emily Lancsar, Stephen Simpson, John Teah |
---|---|
Format: | Article |
Language: | English |
Published: |
National Institute for Health Research
2017-01-01
|
Series: | Health Services and Delivery Research |
Subjects: | |
Online Access: | https://doi.org/10.3310/hsdr05040 |
Similar Items
-
A novel design process for selection of attributes for inclusion in discrete choice experiments: case study exploring variation in clinical decision-making about thrombolysis in the treatment of acute ischaemic stroke
by: Aoife De Brún, et al.
Published: (2018-06-01) -
Higher Platelet-to-Lymphocyte Ratio Is Associated With Worse Outcomes After Intravenous Thrombolysis in Acute Ischaemic Stroke
by: Jing-Han Xu, et al.
Published: (2019-11-01) -
Thrombolysis Outcomes in Acute Ischaemic Stroke Patients with Pre-Existing Cognitive Impairment
by: Isabela V. P. Ramnarine, et al.
Published: (2023-04-01) -
Secondary prevention of patients with ischaemic stroke after recanalization treatment
by: Benesová Michaela, et al.
Published: (2022-07-01) -
Intravenous thrombolysis for acute ischaemic stroke in a hospital without a specialised neuro-intensive care unit
by: N Wiegand, et al.
Published: (2004-01-01)